Ignite Creation Date:
2025-12-24 @ 12:24 PM
Ignite Modification Date:
2026-01-15 @ 1:37 AM
Study NCT ID:
NCT02606461
Status:
COMPLETED
Last Update Posted:
2023-01-23
First Post:
2015-10-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Selinexor in Advanced Liposarcoma
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KCP-330-020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None